Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial. [Phase 2]

View source ↗

Summary

Phase 2 trial update for immediate lymphatic reconstruction to prevent lymphedema; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphedema | Phase 2 | Status: RECRUITING